Physician profile
Amanda Salvado
NPI 1194988154
$2,235.66
in general payments reported to CMS, 2019-2025
14 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $146 · 2021: $89.71 · 2022: $194 · 2023: $1,090 · 2024: $262 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998 · Consulting Fee: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.34 |
| Consulting Fee | $700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galt Pharmaceuticals, LLC | $700.00 | 2023 | Oravig |
| Stryker Corporation | $392.96 | 2019-2025 | Xpress Loprofile, Xpress Ent Dilation System, Cyclone Sinonasal Suction/Irrigation System |
| Abbvie INC. | $245.54 | 2023-2025 | Botox |
| Acclarent, INC | $178.20 | 2019-2023 | Trudi Nav Cable |
| Neurent Medical Limited | $150.95 | 2022-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Aerin Medical INC. | $106.70 | 2020-2023 | |
| Glaxosmithkline, LLC. | $105.65 | 2023-2025 | Nucala |
| Medtronic, INC. | $71.40 | 2024-2025 | Propel |
| Regeneron Healthcare Solutions, INC. | $66.68 | 2023-2024 | Dupixent |
| Phathom Pharmaceuticals, INC. | $63.13 | 2025 | Voquezna |
| Optinose US, INC. | $54.88 | 2024-2025 | |
| Smith+Nephew, INC. | $52.21 | 2019-2024 | Rf20000, Coblation, Tula |
| Merck Sharp & Dohme LLC | $26.40 | 2023 | |
| Genzyme Corporation | $20.96 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Salvado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.